Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKU
-
Homology Medicines to Participate in the 43rd Annual Cowen Healthcare Conference
-
Homology Medicines to Participate in Upcoming Investor Conferences
-
Homology Medicines to Participate in Upcoming Investor and Patient Advocacy Conferences
-
Homology Medicines to Participate in Upcoming Investor and Scientific Conferences
-
Homology Medicines Inc. (FIXX) Prices 5.55M Share Offering at $22.50/Sh
-
Homology Medicines Announces Pricing of Public Offering of Common Stock
-
Homology Medicines Inc. (FIXX) Announces $125M Proposed Public Offering of Common Stock
-
Homology Medicines Announces Proposed Public Offering of Common Stock
-
Homology Medicines Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Update on Recent Accomplishments
-
Homology Medicines to Present at Cowen Healthcare Conference
-
Cowen Starts Homology Medicines (FIXX) at Outperform
-
Homology Medicines Announces Closing of Initial Public Offering
-
Homology Medicines, Inc. (FIXX) Prices 9M Share IPO at $16/Sh
-
Homology Medicines Announces Pricing of Initial Public Offering

